人黑色素瘤中TrkB的表達(dá)以及雷公藤內(nèi)酯醇對(duì)其表達(dá)的影響
[Abstract]:Objective: 1) to study the expression of TrkB in human melanoma. To investigate the role of TrkB in melanoma. 2) to observe the expression of TrkB in human melanoma cell line A875 and the change of TrkB expression in A875 cells treated with triptolide, and to explore the anti-tumor mechanism of triptolide. Methods: 1) immunohistochemical SP method was used to detect the expression of TrkB in 40 cases of human melanoma and 30 cases of human pigmented nevus. 2) the expression of TrkB in 40 cases of human melanoma and 30 cases of human pigmented nevus was detected by immunocytochemistry. RT-PCR and western-blot methods were used to detect the expression of TrkB in A875 cells before and after triptolide treatment. Results: 1) the positive rate of TrkB in melanoma and human pigmented nevus was 77.5% and 16.7%, respectively. There was significant difference between them (P0.01). 2) a > in the cellular immunohistochemical method, the expression of TrkB was positive in A875 cells, and decreased after triptolide treatment. The expression of TrkB protein in A875 cells treated with triptolide was significantly lower than that in untreated cells (P0.05). The expression of TrkB protein in A875 cells treated with triptolide was significantly lower than that in untreated cells (P0.05). The expression of TrkB protein in TrkB treated with triptolide in RT-PCR method was significantly lower than that in untreated cells. The expression was significantly lower than that of A 875 cells treated with triptolide without Tripterygium wilfordii. Conclusion: TrkB is positive in human melanoma tissue and in human melanoma cell line A875, and its high expression may be one of the reasons for the occurrence and development of melanoma. In the study of A875 cell line, triptolide can inhibit the expression of TrkB, and it is suggested that tripterygiolide can inhibit the expression of TNF in human melanoma tissue and human melanoma cell line A875. These results suggest that triptolide may have anti-tumor effect by inhibiting the expression of TrkB.
【學(xué)位授予單位】:華中科技大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2011
【分類號(hào)】:R739.5
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 彭義平;晏哲;杭智輝;;黃藤浸膏片中雷公藤內(nèi)酯醇含量分析[J];湖北中醫(yī)雜志;2011年09期
2 朱四紅;譚布珍;;雷公藤內(nèi)酯醇抑制惡性腫瘤增殖的機(jī)制[J];實(shí)用臨床醫(yī)學(xué);2011年04期
3 劉冬舟;劉翠蓮;洪小平;褚愛(ài)春;;雷公藤內(nèi)酯醇對(duì)系統(tǒng)性紅斑狼瘡患者樹突狀細(xì)胞Toll樣受體-9表達(dá)的影響[J];實(shí)用醫(yī)學(xué)雜志;2011年11期
4 余愛(ài)平;尹伶;張正斌;;TrkB和配體BDNF在宮頸癌及宮頸上皮內(nèi)瘤變組織中的表達(dá)及意義[J];醫(yī)學(xué)研究雜志;2011年06期
5 吳瑛;劉芳;郭文淵;肖亮;陽(yáng)揭宇;謝江平;丁國(guó)善;;雷公藤內(nèi)酯醇下調(diào)P53基因甲基化抑制肝癌SMMC-7721細(xì)胞的增殖[J];中國(guó)腫瘤生物治療雜志;2011年03期
6 白靜;歐倫;李慧;呂華;齊亞娟;;雷公藤提取物血清藥物化學(xué)初步研究[J];中藥藥理與臨床;2011年04期
7 于英蛟;張四洋;陶春梅;王學(xué)梅;楊志偉;;TrkB在結(jié)腸癌中的表達(dá)及其對(duì)LoVo細(xì)胞增殖、凋亡和侵襲的影響[J];中國(guó)現(xiàn)代醫(yī)學(xué)雜志;2011年19期
8 時(shí)瀚;郭姍姍;時(shí)宇靜;金亞宏;高英杰;劉穎;劉方舟;鐘菊迎;崔曉蘭;;MC002誘導(dǎo)人喉癌細(xì)胞Hep-2凋亡及其作用機(jī)制[J];中國(guó)現(xiàn)代醫(yī)藥雜志;2011年06期
9 ;皮膚科學(xué)基礎(chǔ)[J];中國(guó)醫(yī)學(xué)文摘(皮膚科學(xué));2011年03期
10 蘇夢(mèng)翔;高旋;宋敏;杭太俊;沈文斌;宋U,
本文編號(hào):2453854
本文鏈接:http://sikaile.net/yixuelunwen/pifb/2453854.html